Nuzenio

Arcturus Therapeutics

Arcturus Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Arcturus Therapeutics (NASDAQ:ARCT) Announces Earnings Results, Beats Estimates By $0.16 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 02:14:07 GMT Arcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSciAllSci · Fri, 07 Aug 2026 16:13:37 GMT BioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMT CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Cuts Target Price to $20 - MoomooMoomoo · Fri, 07 Aug 2026 12:12:25 GMT ARCT Looks 57.9% Overvalued on GF Value™ - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:13:09 GMT Arcturus Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 22:04:08 GMT Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:20:02 GMT Q2 2026 Arcturus Therapeutics Holdings Inc Earnings Call Transcript - GuruFocusGuruFocus · Thu, 06 Aug 2026 20:30:00 GMT

Timeline

Sat, 08 Aug 2026 02:14:07 GMTArcturus Therapeutics (NASDAQ:ARCT) Announces Earnings Results, Beats Estimates By $0.16 EPS - MarketBeat

Fri, 07 Aug 2026 16:13:37 GMTArcturus and CSL Seqirus terminate sa-mRNA vaccine partnership - AllSci

Fri, 07 Aug 2026 15:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints News

Fri, 07 Aug 2026 12:12:25 GMTCCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Cuts Target Price to $20 - Moomoo

Fri, 07 Aug 2026 08:13:09 GMTARCT Looks 57.9% Overvalued on GF Value™ - GuruFocus

Thu, 06 Aug 2026 22:04:08 GMTArcturus Therapeutics Q2 Earnings Call Highlights - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

ARCT12 live mentions Arcturus Therapeutics Holdings6 live mentions Arcturus5 live mentions Therapeutics4 live mentions Inc4 live mentions Yahoo Finance Arcturus3 live mentions NASDAQ2 live mentions Announces Earnings Results2 live mentions Beats Estimates By2 live mentions CSL Seqirus2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Arcturus Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.